Market Place
Sourcing Support
All News #Library
Biotech
Apnimed Publishes Positive Phase 2 Results of OSA in Lancet
03 Nov 2025 //
PR NEWSWIRE
Apnimed Presents Positive AD109 Phase 3 Data At CHEST Meeting
07 Oct 2025 //
PR NEWSWIRE
Apnimed`s Sleep Apnea Drug Succeeds in Phase 3 Trials
23 Jul 2025 //
FIERCE BIOTECH
Apnimed’s AD109 Shows Positive Results in 2nd Ph3 Sleep Trial
23 Jul 2025 //
PR NEWSWIRE
Apnimed Provides Clinical Updates for Multiple Product Candidates
07 Apr 2025 //
PR NEWSWIRE
Apnimed Appoints Kevin R. Lind as Non-Executive Chairman
11 Mar 2025 //
PR NEWSWIRE
Apnimed To Participate In Needham Biotech Forum
26 Sep 2024 //
PR NEWSWIRE
Apnimed to Participate in the Evercore ISI 2024 Emerging Biotech Conference
22 Feb 2024 //
GLOBENEWSWIRE
Apnimed, a late-stage sleep apnea biotech, eyes IPO in the second half
15 Feb 2024 //
ENDPTS
Two biotechs go public while Apnimed bides its time
02 Oct 2023 //
FIERCE BIOTECH
Apnimed to Participate in the William Blair Virtual Conference
12 Jul 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.